A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas.
A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas. — المؤلف: Trucco, Matteo M — Clinical sarcoma research 2018
- المؤلف
- Trucco, Matteo M
- النشر
- Clinical sarcoma research 2018
- الوصف
- 21 p.